Vascular endothelial growth factor and its soluble receptor in ovarian pathology

Gynecological Endocrinology

Volumn 21, Issue 1, 2005, Pages 50-56

  Artini, P G ^a,c   Cristello, F ^a   Monti, M ^a   Cela, V ^a   Battaglia, C ^b   D'Ambrogio, G ^a   Genazzani, A R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Cystoadenocarcinoma; Endometriosis; Ovarian cyst; Soluble VEGF receptor 1; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CALCULATION; CANCER GROWTH; CYSTADENOCARCINOMA; ENDOMETRIOSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY; OVARY CANCER; OVARY CYST; OVARY ENDOMETRIOSIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

CYST FLUID; CYSTADENOCARCINOMA; CYSTADENOMA, SEROUS; ENDOMETRIOSIS; FEMALE; HUMANS; OVARIAN DISEASES; OVARIAN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 23244454078     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590500099560     Document Type: Article

References (36)

1. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod 2000;6:45-55.
2. Strathy JH, Molgaard CA, Coulman CB. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 1982;38:667-72.
3. Jenkins S, Olive DL, Haney AF. Endometriosis: pathogenic implications of the anatomic distribution. Obstet Gynecol 1986;67:335-8.
4. Halme J, Hammond M, Hulka J, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151-4.
5. Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV, Taylor RN. Interleukin-6 secretion in vitro is upregulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996;81:1118-22.
6. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-18.
7. Smith SK. Angiogenesis. Semin Reprod Endocrinol 1997;15:221-7.
8. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995;146:157-65.
9. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996; 81:353-9.
10. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
11. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 1995;147:33-41.
12. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
13. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
14. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-12.
15. Benjamin LE, Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cells shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997;94:8761-6.
16. Carmeliet P, Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 1998;237:133-57.
17. Grimmond S, Lagercrantz J, Drinkwater C, Silins G, Townson S, Pollock P, Gotley D, Carson E, Rakar S, Nordenskjold M, et al. Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Res 1996;6:124-31.
18. Olofsson B, Pajusola K, Euler GV, Chilov D, Alitalo K, Eriksson U. Genomic organisation of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterisation of a second splice isoform. J Biol Chem 1996;271:19310-17.
19. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14:2475-83.
20. Jakeman L, Winer J, Bennett GL, Altar CA, Ferrara N. Binding sites for vascular endothelial growth factor are localised on endothelial in adult rat tissue. J Clin Invest 1992;89:244-53.
21. de Vries CD, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
22. Fong GH, Zhang L, Bryce DM, Peng J. Increased hemangioblast commitment, not vascular disorganisation in the primary defect in flt-1 knock-out mice. Development 1999;126:3015-25.
23. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by dominant negative Flk-1 mutant. Nature 1994;367:576-9.
24. Krussel JS, Casan EM, Raga F, Hirchenhain J, Wen Y, Huang HY, Bielfeld P, Polan ML. Expression for mRNA for VEGF transmenbraneous receptors Flt-1 and KDR, and the soluble receptor sflt in cycling human endometrium. Mol Hum Reprod 1999;5:452-8.
25. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540-8.
26. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor response, FLT-1 and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324-8.
27. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-3.
28. Fasciani A, D'Ambrogio G, Bocci G, Luisi S, Artini PG, Genazzani AR. High concentration of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod 2000;6:50-4.
29. Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276-80.
30. Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T. The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in ovarian cancer. Int J Gynecol Pathol 1997;16:256-62.
31. Hazelton D, Nicosia R, Nicosia SV. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Clin Cancer Res 1999;5:823-9.
32. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusion. Cancer Res 1993;53:2912-18.
33. Neulen J, Wenzel D, Hornig C, Wunsch E, Weissenborn U, Grunwald K, Buttner R, Weich H. Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols. Hum Reprod 12001;6:621-6.
34. American Fertility Society. Revised American Fertility Society classification of endometriosis. Fertil Steril 1985;43:351-2.
35. Guerriero S, Ajossa S, Risalvato A, Lai MP, Mais V, Angiolucci M, Melis GB. Diagnosis of adnexal malignancies by using color Doppler energy imaging as a secondary test in persistent masses. Ultrasound Obstet Gynecol 1998;11:277-82.
36. Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 1996;74:1105-15.